🇺🇸 FDA
Patent

US 11904057

Nanoparticle-hydrogel composite for nucleic acid molecule delivery

granted A61KA61K31/7105A61K45/06

Quick answer

US patent 11904057 (Nanoparticle-hydrogel composite for nucleic acid molecule delivery) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K31/7105, A61K45/06, A61K47/6455, A61K47/6929